Oral Abstract Session 33: Rhinitis Treatment 2

Wednesday, 7 December 2011: 12:45 - 14:15
Costa Maya 1 (Cancún Center)
Chairpersons:   Joaquim Mullol (Spain) and James Baraniuk (US)
12:45 - 13:00
4209: Patterns of Initiation and Adherence to De Novo Allergen-Specific Immunotherapy Among Adults and Children with Newly-Diagnosed Allergic Rhinitis: Findings From Research Jointly Funded by the AAAAI and ACAAI | Cheryl Hankin (US)
13:00 - 13:15
4210: Effect of Simvastatin on Transforming Growth Factor Beta-1-Induced Myofibroblast Differentiation and Collagen Production in Nasal Polyp-Derived Fibroblasts | Il-Ho Park (South Korea)
13:15 - 13:30
4211: Onset of Action of MP29-02 in the Treatment of Seasonal Allergic Rhinitis | Jonathan Bernstein (US)
13:30 - 13:45
4212: MP29-02 in the Treatment of Nasal Symptoms of Seasonal Allergic Rhinitis | William Wheeler (US)
13:45 - 14:00
4213: A 26-Week Study Evaluating the Safety and Efficacy of Ciclesonide Hydrofluoralkane Nasal Aerosol in Subjects with Perennial Allergic Rhinitis John Karafilidis (US)
14:00 - 14:15
4214: Omalizumab Improves Asthma but Not Nasal Symptoms in Japanese Patients with Severe Allergic Asthma and Rhinitis | Fuyumi Nishihara (Japan)
See more of: Oral Abstract Session
See more of: Abstract Presentations
<< Previous Session | Next Session >>